NEW YORK, Sept. 02, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both dates inclusive (the “Class Period”), of the important September 10, 2024 lead plaintiff deadline. SO WHAT: If you purchased CVS Securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 15, 2024. SO WHAT: If you purchased Stellantis securities during the Cla ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Spire Global, Inc. (NYSE: SPIR) between March 6, 2024 and August 14, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2024. SO WHAT: If you purchased Spire Global securities during the ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Starbucks Corporation (NASDAQ: SBUX) between November 2, 2023 and April 30, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2024. SO WHAT: If you purchased Starbucks securities during ...

NEW YORK, Aug. 31, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock or sellers of puts of MacroGenics, Inc. (NASDAQ: MGNX) between March 7, 2024 and May 9, 2024, both dates inclusive (the “Class Period”), of the important September 24, 2024 lead plaintiff deadline. SO WHAT: If you purchased stock or sold puts of MacroGenics during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a cont ...

NEW YORK, Aug. 31, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the “Class Period”), of the important October 21, 2024 lead plaintiff deadline. SO WHAT: If you purchased Orthofix common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2024. SO WHAT: If you purchased DexCom securities during the Class Period yo ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Orthofix Medical Inc. common stock during the specified Class Period, alleging misleading statements and omissions by the company's management regarding its business and financial condition [1][4]. Group 1: Lawsuit Details - The class action lawsuit pertains to purchasers of Orthofix common stock between October 11, 2022, and September 12, 2023 [1]. - The lawsuit claims that the defendants failed to disclose inappropriate conduct by certain members of Orthofix's management team, which led to investor damages when the truth was revealed [4]. - Investors who purchased stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [2][4]. - A lead plaintiff must file a motion with the court by October 21, 2024, to represent other class members in the litigation [1][2]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest ever against a Chinese company [3]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [3].

NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Orthofix Medical Inc. (NASDAQ: OFIX) between October 11, 2022 and September 12, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2024. SO WHAT: If you purchased Orthofix common stock d ...

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased Sprinklr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or co ...